TAX1BP3 and liver failure: Serum samples from TIP1-treated mice, however, showed a significant decrease in ALT and AST activities, indicating that the treatment of mice with TIP1 alleviated the liver failure caused by LPS-induced inflammation (Fig. 5i, j).